Short Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Drops By 57.4%

Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) saw a large decrease in short interest in November. As of November 15th, there was short interest totalling 14,600 shares, a decrease of 57.4% from the October 31st total of 34,300 shares. Based on an average daily trading volume, of 254,600 shares, the short-interest ratio is presently 0.1 days.

Chugai Pharmaceutical Stock Performance

Shares of CHGCY traded up $0.37 during mid-day trading on Friday, hitting $22.00. 50,912 shares of the company traded hands, compared to its average volume of 128,568. The business has a 50 day moving average of $23.25 and a 200 day moving average of $20.81. Chugai Pharmaceutical has a 1-year low of $14.52 and a 1-year high of $26.00.

About Chugai Pharmaceutical

Chugai Pharmaceutical Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company’s products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng.